LPS also specifically activates TLR4, an important inflammatory receptor in the liver, which promotes NF-κB nuclear entry and the release of inflammatory cytokines and accelerates the development of NASH (Leng et al., 2022). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.